These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 20560029)

  • 1. COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design.
    Mansour S; Roy DC; Bouchard V; Nguyen BK; Stevens LM; Gobeil F; Rivard A; Leclerc G; Reeves F; Noiseux N
    J Cardiovasc Transl Res; 2010 Apr; 3(2):153-9. PubMed ID: 20560029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of intracoronary injection of CD133+ bone marrow stem cells on coronary atherosclerotic progression in patients with STEMI: a COMPARE-AMI IVUS substudy.
    Qiu F; Maehara A; El Khoury R; Généreux P; LaSalle L; Mintz GS; Noiseux N; Roy DC; Gobeil F; Stevens LM; Reeves F; Leclerc G; Rivard A; Mansour S
    Coron Artery Dis; 2016 Jan; 27(1):5-12. PubMed ID: 26340545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
    Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
    Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.
    Bartunek J; Vanderheyden M; Vandekerckhove B; Mansour S; De Bruyne B; De Bondt P; Van Haute I; Lootens N; Heyndrickx G; Wijns W
    Circulation; 2005 Aug; 112(9 Suppl):I178-83. PubMed ID: 16159812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell therapy for the broken heart: mini-organ transplantation.
    Mansour S; Roy DC; Lemieux B; Ouellet C; Stevens LM; Noiseux N
    Transplant Proc; 2009 Oct; 41(8):3353-7. PubMed ID: 19857748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial.
    Colombo A; Castellani M; Piccaluga E; Pusineri E; Palatresi S; Longari V; Canzi C; Sacchi E; Rossi E; Rech R; Gerundini P; Viecca M; Deliliers GL; Rebulla P; Soligo D; Giordano R
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):239-48. PubMed ID: 21372740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
    Traverse JH; Henry TD; Vaughan DE; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Simpson LM; Penn MS; Byrne BJ; Perin EC; Gee AP; Hatzopoulos AK; McKenna DH; Forder JR; Taylor DA; Cogle CR; Baraniuk S; Olson RE; Jorgenson BC; Sayre SL; Vojvodic RW; Gordon DJ; Skarlatos SI; Moyè LA; Simari RD;
    Tex Heart Inst J; 2010; 37(4):412-20. PubMed ID: 20844613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.
    Yerebakan C; Kaminski A; Westphal B; Donndorf P; Glass A; Liebold A; Stamm C; Steinhoff G
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1530-9.e3. PubMed ID: 21664627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133 Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction.
    Mansour S; Roy DC; Bouchard V; Stevens LM; Gobeil F; Rivard A; Leclerc G; Reeves F; Noiseux N
    Bone Marrow Res; 2011; 2011():385124. PubMed ID: 22046562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency.
    Flores-Ramírez R; Uribe-Longoria A; Rangel-Fuentes MM; Gutiérrez-Fajardo P; Salazar-Riojas R; Cervantes-García D; Treviño-Ortiz JH; Benavides-Chereti GJ; Espinosa-Oliveros LP; Limón-Rodríguez RH; Monreal-Puente R; González-Treviño JL; Rojas-Martínez A
    Cardiovasc Revasc Med; 2010; 11(2):72-8. PubMed ID: 20347795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
    Traverse JH; Henry TD; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Forder JR; Byrne BJ; Hatzopoulos AK; Penn MS; Perin EC; Baran KW; Chambers J; Lambert C; Raveendran G; Simon DI; Vaughan DE; Simpson LM; Gee AP; Taylor DA; Cogle CR; Thomas JD; Silva GV; Jorgenson BC; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Smith DX; Baraniuk S; Piller LB; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2011 Nov; 306(19):2110-9. PubMed ID: 22084195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experience.
    Limsuwan A; Pienvichit P; Limpijankit T; Khowsathit P; Hongeng S; Pornkul R; Siripornpitak S; Boonbaichaiyapruk S
    Clin Cardiol; 2010 Aug; 33(8):E7-12. PubMed ID: 20632394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium.
    Agbulut O; Vandervelde S; Al Attar N; Larghero J; Ghostine S; Léobon B; Robidel E; Borsani P; Le Lorc'h M; Bissery A; Chomienne C; Bruneval P; Marolleau JP; Vilquin JT; Hagège A; Samuel JL; Menasché P
    J Am Coll Cardiol; 2004 Jul; 44(2):458-63. PubMed ID: 15261948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
    Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
    Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery.
    Yang Z; Zhang F; Ma W; Chen B; Zhou F; Xu Z; Zhang Y; Zhang D; Zhu T; Wang L; Wang H; Ding Z; Zhang Y
    Cardiovasc Ther; 2010 Dec; 28(6):380-5. PubMed ID: 20337639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction).
    Malliaras K; Makkar RR; Smith RR; Cheng K; Wu E; Bonow RO; Marbán L; Mendizabal A; Cingolani E; Johnston PV; Gerstenblith G; Schuleri KH; Lardo AC; Marbán E
    J Am Coll Cardiol; 2014 Jan; 63(2):110-22. PubMed ID: 24036024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
    Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
    Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.
    Gyöngyösi M; Wojakowski W; Lemarchand P; Lunde K; Tendera M; Bartunek J; Marban E; Assmus B; Henry TD; Traverse JH; Moyé LA; Sürder D; Corti R; Huikuri H; Miettinen J; Wöhrle J; Obradovic S; Roncalli J; Malliaras K; Pokushalov E; Romanov A; Kastrup J; Bergmann MW; Atsma DE; Diederichsen A; Edes I; Benedek I; Benedek T; Pejkov H; Nyolczas N; Pavo N; Bergler-Klein J; Pavo IJ; Sylven C; Berti S; Navarese EP; Maurer G;
    Circ Res; 2015 Apr; 116(8):1346-60. PubMed ID: 25700037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the COMPARE-AMI trial: First report of long-term safety of CD133+ cells.
    Haddad K; Potter BJ; Matteau A; Reeves F; Leclerc G; Rivard A; Gobeil F; Roy DC; Noiseux N; Mansour S
    Int J Cardiol; 2020 Nov; 319():32-35. PubMed ID: 32553596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.